The Role of Epidermal Growth Factor Receptor in Diabetes-Induced Cardiac Dysfunction

被引:38
作者
Akhtar, Saghir [1 ]
Benter, Ibrahim Fadil [1 ]
机构
[1] Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Safat, Kuwait
关键词
Cardiac Dysfunction; EGF; EGFR; RAAS; erbB; Diabetes; Heart Ischemia-Reperfusion Injury;
D O I
10.5681/bi.2013.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The incidence of diabetes mellitus is increasing rapidly and set to reach near epidemic proportions with the latest estimates suggesting that by 2030 there will be over 550 million people with this debilitating disease. Cardiovascular complications and dysfunctions are three-to eight-folds more likely in diabetic patients and are major causes of increased mortality. The exact underlying mechanisms for the development of complications of the diabetic heart are poorly understood and may involve multiple signaling pathways that are affected by hyperglycemia. This focused article reviews the recent evidence for a possible dual role of epidermal growth factor receptor signaling in diabetes-induced cardiac dysfunction.
引用
收藏
页码:5 / 9
页数:5
相关论文
共 50 条
  • [1] The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications
    Shraim, Bara A.
    Moursi, Moaz O.
    Benter, Ibrahim F.
    Habib, Abdella M.
    Akhtar, Saghir
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [2] Diabetes-induced renal vascular dysfunction is normalized by inhibition of epidermal growth factor receptor tyrosine kinase
    Benter, IF
    Yousif, MHM
    Hollins, AJ
    Griffiths, SM
    Akhtar, S
    JOURNAL OF VASCULAR RESEARCH, 2005, 42 (04) : 284 - 291
  • [3] Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed
    Benter, IF
    Yousif, MHM
    Griffiths, SM
    Benboubetra, M
    Akhtar, S
    BRITISH JOURNAL OF PHARMACOLOGY, 2005, 145 (06) : 829 - 836
  • [4] Novel therapeutic effects of sesamin on diabetes-induced cardiac dysfunction
    Tran Duong Thuy
    Nam Nhut Phan
    Wang, Chih-Yang
    Yu, Han-Gang
    Wang, Shu-Yin
    Huang, Pung-Ling
    Do, Yi-Yin
    Lin, Yen-Chang
    MOLECULAR MEDICINE REPORTS, 2017, 15 (05) : 2949 - 2956
  • [5] Leukocytic toll-like receptor 2 knockout protects against diabetes-induced cardiac dysfunction
    Lei, Lei
    Hu, Houxiang
    Lei, Yan
    Feng, Jie
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 506 (03) : 668 - 673
  • [6] Role of epidermal growth factor receptor (EGFR) in corneal remodelling in diabetes
    Akhtar, Saeed
    Almubrad, Turki
    Bron, Anthony J.
    Yousif, Mariam H. M.
    Benter, Ibrahim F.
    Akhtar, Saghir
    ACTA OPHTHALMOLOGICA, 2009, 87 (08) : 881 - 889
  • [7] The Role of Activin A in Maternal Diabetes-Induced Cardiac Malformations
    Zhao, Zhiyong
    CIRCULATION RESEARCH, 2012, 111 (04)
  • [8] The Role of the Epidermal Growth Factor Receptor in Breast Cancer
    Samuel K. Chan
    Mark E. Hill
    William J. Gullick
    Journal of Mammary Gland Biology and Neoplasia, 2006, 11 : 3 - 11
  • [9] The role of the epidermal growth factor receptor in breast cancer
    Chan, Samuel K.
    Hill, Mark E.
    Gullick, William J.
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2006, 11 (01) : 3 - 11
  • [10] Distinct role of estrogen receptor-alpha and beta on postmenopausal diabetes-induced vascular dysfunction
    Bansal, Seema
    Chopra, Kanwaljit
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2014, 206 : 51 - 59